Lisa McClain, Representative
sell disclosed on 21 Nov 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +7.5%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Novartis AG Common Stock (NVS)
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
16 disclosures
5 insiders
0 cluster signals
+3.1% avg. 30d outcome (15 of 16)
Company facts
- Ticker / ISIN
- NVS / Not available
- Exchange
- Not available
- Country
- US
- Sector
- Not available
Disclosure history
Lisa McClain, Representative
buy disclosed on 21 Nov 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +7.5%
Lisa McClain, Representative
sell disclosed on 21 Nov 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +7.5%
Lisa McClain, Representative
sell disclosed on 22 Oct 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -3.1%
Lisa McClain, Representative
buy disclosed on 22 Oct 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -3.1%
Lisa McClain, Representative
sell disclosed on 13 Aug 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +2.4%
Lisa McClain, Representative
sell disclosed on 13 Aug 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +2.4%
Lisa McClain, Representative
buy disclosed on 13 Aug 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +2.4%
Lisa McClain, Representative
buy disclosed on 13 Aug 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +2.4%
Lisa McClain, Representative
buy disclosed on 13 Aug 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +2.4%
George Whitesides, Representative
sell disclosed on 23 Apr 2025 via House STOCK Act disclosures
- Transaction value
- US$100,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +2.4%
Daniel Goldman, Representative
sell disclosed on 13 Aug 2023 via House STOCK Act disclosures
- Transaction value
- US$50,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Daniel Goldman, Representative
buy disclosed on 17 Apr 2023 via House STOCK Act disclosures
- Transaction value
- US$50,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +3.3%
Daniel Goldman, Representative
sell disclosed on 20 Mar 2023 via House STOCK Act disclosures
- Transaction value
- US$15,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +17.5%
Kevin Hern, Representative
sell disclosed on 14 Feb 2023 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -1.3%
John Rutherford, Representative
sell disclosed on 19 Apr 2022 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -3.2%